Author/Authors :
J de Kraker، نويسنده , , N Graf، نويسنده , , H van Tinteren، نويسنده , , F Pein، نويسنده , , K. Sandstedt، نويسنده , , J. Godzinski، نويسنده , , MF Tournade ، نويسنده ,
Abstract :
Background
Present treatment for Wilmsʹ tumour is very successful. Now, efforts are aimed at reducing toxicity and burden of treatment by shortening schedules without loss of effectiveness. The objective of this randomised trial was to assess whether post